About Artemis Global Life Sciences Limited
Data last updated:
Artemis Global Life Sciences Limited was a public limited company based in New Delhi, Delhi, India, operated as a subsidiary of Constructive Finance Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the hospital and clinical services segment of the healthcare sector. It was incorporated on 25 March 2011.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN L85191DL2011PLC216530. The company has 2 GST registrations on record, none of which is active. It is a listed company.
The company had an authorised share capital of ₹20 Cr and a paid-up capital of ₹13.24 Cr. It was formerly known as Ptl Projects Limited. It was led by directors including Devlina Chakravarty (Managing Director) and Neeraj Singh Kanwar.
Its last annual general meeting (AGM) was held on 14 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at 414/1 4th Floor Dda Commercial Complex District Centre Janakpuri, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2018, the company reported a revenue of ₹507.09 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹26.28 Cr (net margin 5.2%) and EBITDA of ₹63.13 Cr (EBITDA margin 12.4%).
Its group structure included 3 subsidiaries.
The company was associated with 2 brands: Artemis Cardiac Care and Artemis Global Life Sciences. The company has 2 deals on record (2 market trades); the latest was in September 2018. Its 10 peer companies in the Healthcare industry (Multi Specialty Hospitals) are compared by revenue, 5 larger and 5 smaller; the largest is Regency Hospital Limited with revenue of ₹561.64 Cr.
The last known website on record is aglsl.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address414/1 4th Floor Dda Commercial Complex District Centre Janakpuri, New Delhi, Delhi, India – 110058
- IndustryHealthcare, Hospitals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Artemis Global Life Sciences Limited
The main business activity of Artemis Global Life Sciences is hospital and medical care. In detail, this covers hospital activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Artemis Global Life Sciences Limited FY 2018 filings available
Artemis Global Life Sciences Limited reported revenue of ₹507.09 Cr (up 8% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR) of Artemis Global Life Sciences Limited
Revenue rose 8% in the latest year. EBITDA rose 10% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Artemis Global Life Sciences Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹63.13 Cr | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹26.28 Cr | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Artemis Global Life Sciences Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 12.4% | •••• | •••• | •••• |
| Net Profit Margin | 5.2% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Artemis Global Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Artemis Global Life Sciences Limited
Artemis Global Life Sciences Limited is compared with the companies closest to it by revenue in the Healthcare industry (Multi Specialty Hospitals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Regency Hospital Limited | ₹561.64 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Kanpur, Uttar Pradesh, India |
| Manipal Hospitals (Dwarka) Private Limited | ₹543.09 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Bangalore, Karnataka, India |
| Hometrail Buildtech Private Limited | ₹524.9 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | New Delhi, Delhi, India |
| Imperial Hospital and Research Centre Limited | ₹522.14 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Banaglore, Karnataka, India |
| Yashoda Hospital and Research Centre Limited | ₹508.47 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Artemis Global Life Sciences Limited this company | ₹507.09 Cr (FY 2018) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
| Fortis Hospotel Limited | ₹502.92 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Gurgaon, Haryana, India |
| Sterling Addlife India Private Limited | ₹496.65 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Ahmedabad, Gujarat, India |
| Blue Sapphire Healthcares Private Limited | ₹490.48 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | New Delhi, Delhi, India |
| Ankura Medical & Research Centre Private Limited | ₹483.03 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Hyderabad, Telangana, India |
| Ganesh Park Centre Private Limited | ₹482.22 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Salem, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Artemis Global Life Sciences by revenue in the Healthcare industry (Multi Specialty Hospitals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Artemis Global Life Sciences Limited
Artemis Global Life Sciences Limited is audited by Anand Dua & Associates for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Anand Dua & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors and KMP of Artemis Global Life Sciences Limited
Artemis Global Life Sciences Limited currently reports 8 directors and 2 key managerial personnel. 2 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devlina Chakravarty | Managing Director | 04 Aug 2017 | 9 Years 2 Months | As last reported |
| Neeraj Singh Kanwar Also directs: Artemis Medicare Services Limited, PTL Enterprises Limited, Apollo Tyres Limited. and 3 more | Director | 30 Mar 2017 | 9 Years 6 Months | As last reported |
| Akshaykumar Narendrasinhji Chudasama Also directs: Wyoma Art Consultants LLP, Bhansali Trade Ventures LLP, MNM Gruh Nirman LLP and 5 more | Director | 30 Mar 2017 | 9 Years 6 Months | As last reported |
| Sanjaya Baru | Director | 30 Mar 2017 | 9 Years 6 Months | As last reported |
| Ugar Sain Anand | Director | 04 Aug 2017 | 9 Years 2 Months | As last reported |
| Harish Bahadur Also directs: Sunrays Global Consultants LLP, PTL Enterprises Limited, Swaranganga Consultants Private Limited and 1 more | Director | 25 Mar 2011 | 15 Years 6 Months | As last reported |
Ownership and Shareholding of Artemis Global Life Sciences Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Artemis Global Life Sciences Limited
Artemis Global Life Sciences Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Artemis Global Life Sciences Limited
Artemis Global Life Sciences Limited has 2 deals on record (2 market trades); the latest was in September 2018.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2018 | Market trade | ₹5.48 Cr | Buyer: Ratnabali Equity Private Limited Seller: Ratnabali Capital Markets Private Limited |
| Nov 2017 | Market trade | ₹4.45 Cr | Buyer: Ratnabali Investment Private Limited Seller: Ratnabali Capital Markets Private Limited |
Full deal history
All 2 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Associated Brands with Artemis Global Life Sciences Limited
Artemis Global Life Sciences operates two associated brands: Artemis Cardiac Care and Artemis Global Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Operates a chain of hospitals specializing in cardiology care. | artemiscardiac.com | |
| Retailer of medical equipments | aglsl.in |
Employees and EPFO Compliance at Artemis Global Life Sciences Limited
Employment history and EPFO contributions of people linked to Artemis Global Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Artemis Global Life Sciences Limited
Artemis Global Life Sciences has 3 subsidiary companies. This group structure data is as of FY 2018. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Artemis Health Sciences Limited | U33111DL2005PLC144156 | Locked |
| Athena Eduspark Limited | U80221DL2011PLC225198 | Locked |
| Artemis Medicare Services Limited | U85110DL2004PLC126414 | Locked |
Showing major subsidiaries. Total: 3.
CIN History of Artemis Global Life Sciences Limited
Artemis Global Life Sciences has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L85191DL2011PLC216530, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85191DL2011PLC216530 | Current |
| U85191DL2011PLC216530 | Previous |
| U27101DL2011PLC216530 | Previous |
Recent Activity on Artemis Global Life Sciences Limited
Artemis Global Life Sciences Limited has 14 board changes on record since 2011: 12 appointments and 2 cessations. The latest: Devlina Chakravarty was appointed as Managing Director on 04 Aug 2017.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Artemis Global Life Sciences Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Artemis Global Life Sciences Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Artemis Global Life Sciences Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Artemis Global Life Sciences Limited
Artemis Global Life Sciences has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Artemis Global Life Sciences Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Artemis Global Life Sciences Limited
Artemis Global Life Sciences has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Artemis Global Life Sciences was a public limited company based in New Delhi, Delhi, India. The company worked in hospitals, within the healthcare industry. It was incorporated on 25 March 2011 and is registered under CIN L85191DL2011PLC216530. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Artemis Global Life Sciences was incorporated on 25 March 2011. It is registered with the Registrar of Companies, Delhi.
Artemis Global Life Sciences had 10 directors and KMP:
- Devlina Chakravarty - Managing Director
- Neeraj Singh Kanwar - Director
- Akshaykumar Narendrasinhji Chudasama - Director
- Sanjaya Baru - Director
- Ugar Sain Anand - Director
- Harish Bahadur - Director
- Onkar Kanwar - Director
- Subbaraman Narayan - Director
- Aastha Kalra - Cfo
- Anuj Sood - Company Secretary
The CIN (Corporate Identification Number) of Artemis Global Life Sciences is L85191DL2011PLC216530. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes, Artemis Global Life Sciences is a listed company.
The registered office of Artemis Global Life Sciences is at 4141 4th Floor Dda Commercial Complex District Centre Janakpuri, New Delhi, Delhi, India – 110058.
Artemis Global Life Sciences can be reached through the website aglsl.in. Its registered office is in New Delhi, Delhi, India.
Artemis Global Life Sciences reported revenue of ₹507.09 Cr for FY 2018 (up 8% YoY).
Artemis Global Life Sciences has an authorised share capital of ₹20 Cr and a paid-up capital of ₹13.24 Cr.
Artemis Global Life Sciences reported a net profit of ₹26.28 Cr (net margin 5.2%) and EBITDA of ₹63.13 Cr (EBITDA margin 12.4%) for FY 2018, as per its filed financial statements.